Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
58 items

Powerful enzyme that tamps down inflammation holds promise for protecting eyes in diabetes, premature birth

October 12, 2022

An enzyme under study to treat certain cancers is also showing promise in reducing the significant vision damage that can result from diabetes and premature birth, scientists report.

Noninvasive technique collects sufficient tear fluid to look for biomarkers of health and disease

May 27, 2022

Scientists from Augusta University have fine-tuned a non-invasive and efficient way to evaluate the tear film for clues about wellness and disease.
Green iris

Report on anterior segment inflammation and immunity posted

February 2, 2022

Part of the Anterior Segment Initiative, the meeting addressed gaps in knowledge, barriers to new therapies, and promising areas for research.
Phoebe Lin, MD, PhD

Pathway to better eye health runs through the gut

December 21, 2021

Ocular inflammation research from OHSU targets gastrointestinal microbes.

Reimagining immunity in the eye

December 8, 2021

In a new study, the researchers show that immune cells respond to the lens, not just following an acute injury in the eye, but also to long-lasting inflammation.
Mouse retina

NIH scientists discover new B cell that tempers autoimmunity

December 2, 2021

Findings in mice point to potential therapies for blinding eye disease uveitis and multiple sclerosis

Small amounts of carbon monoxide may help protect vision in diabetes

November 4, 2021

The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.
Brad Gelfand, Ph.D., in the laboratory

Prozac Pegged as Potential Treatment for a Leading Cause of Blindness

October 21, 2021

An antidepressant best known as Prozac could offer the first treatment for the leading cause of blindness among people over 50, new research from the University of Virginia School of Medicine suggests.

Toxic DNA Buildup May Drive Macular Degeneration

September 30, 2021

Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.
Eye diagram showing the uvea, optic nerve, retina, sclera, cornea and pupil.

International coalition classifies 25 subtypes of uveitis, an inflammatory eye disease

June 7, 2021

An international coalition of eye researchers used machine learning to develop classification criteria for 25 of the most common types of uveitis, a collection of over 30 diseases characterized by inflammation inside the eye.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248